Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,088 | 33,176 | 126,435 | 17,213 | 8,707 |
| Marketable Securities | 28,018 | 36,106 | 5,095 | N/A | N/A |
| Receivables | 14,055 | 7,652 | 5,299 | 2,412 | N/A |
| Inventories | 17,543 | 11,913 | 10,330 | 6,261 | N/A |
| Other current assets | 0 | 0 | 0 | 25 | 225 |
| TOTAL | $106,984 | $90,751 | $148,989 | $27,814 | $9,782 |
| Non-Current Assets | |||||
| PPE Net | 15,526 | 12,581 | 9,886 | 8,989 | 4,171 |
| Intangibles | 2,110 | 2,441 | 2,697 | 3,015 | 0 |
| Other Non-Current Assets | 105 | 691 | 643 | 0 | 25 |
| TOTAL | $17,741 | $15,713 | $13,226 | $12,003 | $4,196 |
| Total Assets | $124,725 | $106,464 | $162,215 | $39,817 | $13,978 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,234 | 1,949 | 2,352 | 1,693 | 723 |
| Accrued Expenses | 2,121 | 2,920 | 1,874 | 1,531 | N/A |
| Other current liabilities | 5,582 | 2,663 | 4,086 | 5,151 | 1,757 |
| TOTAL | $26,520 | $18,094 | $14,599 | $17,052 | $16,658 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,275 | 29,440 | 29,397 | N/A | N/A |
| Deferred Revenues | 1,822 | 840 | 411 | 2,483 | 308 |
| Other Non-Current Liabilities | 2,719 | 1,658 | 795 | 2,000 | 0 |
| TOTAL | $34,737 | $33,798 | $32,079 | $4,179 | $685 |
| Total Liabilities | $61,257 | $51,892 | $46,678 | $21,231 | $17,342 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,028 | 2,371 | 2,294 | N/A | N/A |
| Common Shares | 30 | 24 | 23 | 0 | 0 |
| Retained earnings | -321,133 | -248,715 | -169,191 | -106,052 | -72,730 |
| Other shareholders' equity | 20 | 8 | 0 | 124,638 | 67,930 |
| TOTAL | $63,468 | $54,572 | $115,537 | $18,586 | $-3,365 |
| Total Liabilities And Equity | $124,725 | $106,464 | $162,215 | $39,817 | $13,978 |